Recent Quotes (30 days)

You have no recent quotes
chg | %

Cangene Corporation news

  
Showing stories 1 - 10 of about 71   

Articles published

CNJ 0.0000
price chart
Cangene To Be Acquired By Emergent BioSolutions For US$222 Million
Readers are referred to the cautionary notes regarding Forward-looking Information and non-IFRS Financial Measures at the end of this release.
Related articles »  
Cangene takeover might not be a bad thing
This article was published 19/12/2013 (1484 days ago), so information in it may no longer be current. One of the facts of life in the global economy is commercial ownership of assets is going to be bought and sold throughout that global marketplace ...
Related articles »  
Cangene bought by US rival for $236-million, latest Canadian biotech taken private
Another of Canada's small biotechnology companies is disappearing from the public markets, with the proposed acquisition of Winnipeg-based Cangene Corp. by a U.S. rival. Emergent BioSolutions of Rockville, Maryland, has signed a deal to buy Cangene for ...
Emergent BioSolutions pays $222M to acquire life sciences firm Cangene Corp.  Washington Post
Cangene to be acquired by Emergent BioSolutions  CBC.ca
Related articles »  
Emergent BioSolutions Completes Acquisition of Cangene Corporation
ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of Cangene Corporation for $222 million in cash. After payment by Cangene of transaction related costs, Emergent expects to ...
Related articles »  
CANGENE bioPHARMA FACILITY RENOVATION IS COMPLETE AND OPERATING AT EXPANDED ...
BALTIMORE AND WINNIPEG, May 2 /PRNewswire/ - Cangene Corporation's Baltimore-based injectable pharmaceutical contract-manufacturing subsidiary, Cangene bioPharma, Inc., has completed a US$11-million renovation of its sterile filling and support ...
Cangene Names John A. Sedor as President and Chief Executive Officer
TORONTO and WINNIPEG, Aug. 16, 2011 /PRNewswire/ - Cangene Corporation (TSX: CNJ), a biopharmaceutical company primarily focused on specialty plasma products, today announces that its board of directors has unanimously appointed John A. Sedor as ...
Ipsen and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale ...
Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) and Inspiration Biopharmaceuticals Inc. (Inspiration) today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation (TSX: CNJ) (Cangene ...
Related articles »  
Emergent BioSolutions Announces Executive Management Team of New Spin-Off ...
Mr. Adelman will continue to lead all commercial functions at Aptevo as VP, Commercial Operations, a position that he has held since 2012 at Cangene Corporation, which was acquired by Emergent in 2014. Mr. Adelman brings over 20 years of industry ...
Kane Biotech Announces New Chief Financial Officer
Mr. Dupuis has more than 25 years of financial leadership experience across a broad range of industries including 15 years at Cangene Corporation, a former Canadian TSX-traded biotechnology company, where he progressed to the role of Senior Director of ...
A bloody mess: The story behind paid plasma in Canada
Protest and political debate ensued. In December 2014, Ontario passed legislation banning payment for blood, as Qu�bec had done two decades earlier (Health Canada is responsible for the safety of the blood system and approves blood collection ...